October 18, 2019 10:54 AM EDT

Ansun Biopharma closes $80M Series B; RedHill Biopharma ties up with Cosmo Pharmaceuticals

Kathy Wong

Editor

→ San Diego-based Ansun Biopharma recently closed an $80 million Series B funding round, led by China Investors, according to ChinaBio Today. The funds …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ansun Biopharma closes $80M Series B; RedHill Biopharma ties up with Cosmo Pharmaceuticals

Kathy Wong

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA approves first drug to treat ultra-rare lipid storage disease

Will CRISPR matter?

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

An­sun Bio­phar­ma clos­es $80M Se­ries B; Red­Hill Bio­phar­ma ties up with Cos­mo Phar­ma­ceu­ti­cals

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Ansun Biopharma closes $80M Series B; RedHill Biopharma ties up with Cosmo Pharmaceuticals